Literature DB >> 17554753

Estimation of the marginal survival time in the presence of dependent competing risks using inverse probability of censoring weighted (IPCW) methods.

Yutaka Matsuyama1, Takuhiro Yamaguchi.   

Abstract

In medical studies, there is interest in inferring the marginal distribution of a survival time subject to competing risks. The Kyushu Lipid Intervention Study (KLIS) was a clinical study for hypercholesterolemia, where pravastatin treatment was compared with conventional treatment. The primary endpoint was time to events of coronary heart disease (CHD). In this study, however, some subjects died from causes other than CHD or were censored due to loss to follow-up. Because the treatments were targeted to reduce CHD events, the investigators were interested in the effect of the treatment on CHD events in the absence of causes of death or events other than CHD. In this paper, we present a method for estimating treatment group-specific marginal survival curves of time-to-event data in the presence of dependent competing risks. The proposed method is a straightforward extension of the Inverse Probability of Censoring Weighted (IPCW) method to settings with more than one reason for censoring. The results of our analysis showed that the IPCW marginal incidence for CHD was almost the same as the lower bound for which subjects with competing events were assumed to be censored at the end of all follow-up. This result provided reassurance that the results in KLIS were robust to competing risks.

Entities:  

Mesh:

Year:  2008        PMID: 17554753     DOI: 10.1002/pst.290

Source DB:  PubMed          Journal:  Pharm Stat        ISSN: 1539-1604            Impact factor:   1.894


  9 in total

1.  Limitation of inverse probability-of-censoring weights in estimating survival in the presence of strong selection bias.

Authors:  Chanelle J Howe; Stephen R Cole; Joan S Chmiel; Alvaro Muñoz
Journal:  Am J Epidemiol       Date:  2011-02-02       Impact factor: 4.897

2.  Double inverse-weighted estimation of cumulative treatment effects under nonproportional hazards and dependent censoring.

Authors:  Douglas E Schaubel; Guanghui Wei
Journal:  Biometrics       Date:  2011-03       Impact factor: 2.571

3.  On the Use of Covariate Supersets for Identification Conditions.

Authors:  Paul N Zivich; Bonnie E Shook-Sa; Jessie K Edwards; Daniel Westreich; Stephen R Cole
Journal:  Epidemiology       Date:  2022-04-05       Impact factor: 4.860

4.  A comparison of ad hoc methods to account for non-cancer AIDS and deaths as competing risks when estimating the effect of HAART on incident cancer AIDS among HIV-infected men.

Authors:  Meredith S Shiels; Stephen R Cole; Joan S Chmiel; Joseph Margolick; Jeremy Martinson; Zuo-Feng Zhang; Lisa P Jacobson
Journal:  J Clin Epidemiol       Date:  2009-10-31       Impact factor: 6.437

5.  Tuberculosis treatment and risk of stavudine substitution in first-line antiretroviral therapy.

Authors:  Daniel J Westreich; Ian Sanne; Mhairi Maskew; Babatyi Malope-Kgokong; Francesca Conradie; Pappie Majuba; Michele Jonsson Funk; Jay S Kaufman; Annelies Van Rie; Patrick Macphail
Journal:  Clin Infect Dis       Date:  2009-06-01       Impact factor: 9.079

6.  Competing risk bias to explain the inverse relationship between smoking and malignant melanoma.

Authors:  Caroline A Thompson; Zuo-Feng Zhang; Onyebuchi A Arah
Journal:  Eur J Epidemiol       Date:  2013-05-23       Impact factor: 8.082

7.  Modeling potential time to event data with competing risks.

Authors:  Liang Li; Bo Hu; Michael W Kattan
Journal:  Lifetime Data Anal       Date:  2013-09-24       Impact factor: 1.588

8.  Prediction meets causal inference: the role of treatment in clinical prediction models.

Authors:  Nan van Geloven; Sonja A Swanson; Chava L Ramspek; Kim Luijken; Merel van Diepen; Tim P Morris; Rolf H H Groenwold; Hans C van Houwelingen; Hein Putter; Saskia le Cessie
Journal:  Eur J Epidemiol       Date:  2020-05-22       Impact factor: 8.082

9.  Estimating Counterfactual Risk Under Hypothetical Interventions in the Presence of Competing Events: Crystalline Silica Exposure and Mortality From 2 Causes of Death.

Authors:  Andreas M Neophytou; Sally Picciotto; Daniel M Brown; Lisa E Gallagher; Harvey Checkoway; Ellen A Eisen; Sadie Costello
Journal:  Am J Epidemiol       Date:  2018-09-01       Impact factor: 4.897

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.